Free cash flow · 2015–2023

Ascendis Pharma free cash flow

−$508M+$29.3M · FY2023

Ascendis Pharma (ASND) reported −$508M in free cash flow for fiscal 2023, +$29.3M from the year before.

−$49.4M2015−$67.4M2016−$108M2017−$167M2018−$203M2019−$333M2020−$522M2021−$537M2022−$508M2023
Ascendis Pharma — Free cash flow, 2015–2023
Fiscal yearFree cash flowChangeFiling
FY2023−$508M+$29.3MDerived
FY2022−$537M−$15.2MDerived
FY2021−$522M−$189MDerived
FY2020−$333M−$130MDerived
FY2019−$203M−$35.7MDerived
FY2018−$167M−$58.6MDerived
FY2017−$108M−$41.1MDerived
FY2016−$67.4M−$18.0MDerived
FY2015−$49.4M—Derived

Free cash flow — Free cash flow is operating cash flow minus capital expenditure: what is left once the company has paid to maintain and expand its asset base. We calculate it from two lines in the same filing, and a company is only ranked here if it reported both.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.

Calculated from two reported figures, so it has no single filing of its own.

Free cash flow at companies of similar size

Full ranking by free cash flow →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Ascendis Pharma free cash flow |url=https://companiesranked.com/en/company/ascendis-pharma/free-cash-flow |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Ascendis Pharma free cash flow. CompaniesRanked. https://companiesranked.com/en/company/ascendis-pharma/free-cash-flow

BibTeX

@misc{companiesranked-en-company-ascendis-pharma-free-cash-flow-2026,
  author       = {{CompaniesRanked}},
  title        = {{Ascendis Pharma free cash flow}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/ascendis-pharma/free-cash-flow}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Ascendis Pharma overview